JERUSALEM and MUMBAI, India, December 21, 2020 / PRNewswire / – VOTIS Subdermal Imaging Technologies, Ltd., an Israeli company, and ii Ventures Private Limited (iiV), an Indian company, announced today that they have submitted a memorandum of understanding to develop a system to to screen largely rural people. Indian population for peripheral artery disease (PAD). The devices, which allow early detection of the disease before susceptible symptoms appear, use the same technology that VOTIS builds into other devices intended for use in the US. and Europe.
“PAD suffers between 41 and 54 million Indians. Many of these people are poor, illiterate, and do not have access to good health care,” said Alfred Arambhan, Co-Founder and Mentor of iiV. “There is a great need for a system that is convenient, error-free and affordable. We found it in VOTIS technology.”
“In India, access to health care among the rural population is very limited,” Mr Arambhan explained. “Protective healthcare is particularly difficult to implement. In poor rural communities, it is very important to keep feet. As rural rural life, when someone loses a foot to amputation it is in a very good economic condition. hopeless, even compared to the urban poor. “
Follow Mr. Arambhan, “India has been named the diabetic capital of the world. Our first plan is to deploy VOTIS solutions in small towns across India, and to create a robust and reliable platform for the future introduction and launch of similar tools and solutions. We are grateful that our plan has received encouragement and support from Government, private and NGO sources in India. “
“Our technology is particularly suitable for the Indian market,” he said Merrill Weber, Chief Executive and President of VOTIS. “Our devices are completely non-invasive and do not use X-rays (Roentgen) or other ionizing radiation. They are cheap and reliable. India, the screening tools allow easy, intuitive use. This will allow tests to be carried out by technicians and nurses in the villages rather than medical doctors at hospitals or clinics. People found with PAD will be immediately referred to specific areas where they can receive appropriate medical treatment. With early disease identification and rapid access to medical care, we expect that the incidence of PAD-related complications will be significantly reduced. “
Mr Arambhan said, “We see this plan as a game changer in the Preventative Healthcare Center in India. “
The VOTIS devices use vascular optical tomographic imaging, or VOTI, imaging technology developed under the direction of Professor. Andreas Hielscher, professor and chair of the newly established Department of Biomedical Engineering at the New York University Tandon School of Engineering. The technology was developed in Professor Hielscher’s optical biology and radiation laboratory, which he ran as professor of biochemical, radiation and electrical engineering at the Fu Foundation’s School of Engineering and Applied Sciences at Columbia University.
VOTIS plans to release its devices commercially in 2022.
About VOTIS Subdermal Imaging Technologies, Ltd.
VOTIS Subdermal Imaging Technologies, Ltd. is an Israeli corporate organization that is developing a series of devices that will be used to help diabetic patients keep their feet up. The first device, the PedCheck™, is used to screen asymptomatic patients ’legs for PAD. If a PAD is found, then the second device, the PedScan™, is used to monitor and monitor the extent of disease and the effect of treatments applied by the patient’s physician. The third engine, the PedFlo™, is used during a rehabilitation procedure, to inform the working doctor about the level of blood flow in the leg. All three VOTIS tools use the same technology, software and system architecture. They are safe, non-invasive, and free from ionizing radiation. More information is available at http://www.votis.net.
Mu ii Ventures Private Limited
ii Ventures Private Limited was co-founded and managed by Alfred Arambhan, an early associate of the Israel India Business and Cultural industry for the past 18 years. It is a Mumbaiestablished serial entrepreneur. Mr. Arambhan founded iiV to bring Israel knowledge, technology and experience to India in place Health, Agri, and Deep Tech. iiV received an invitation from a Singapore established US $ 50 Million funding to participate in their Business Plan. Mr. Arambhan’s daughter, Pooja Armbhan, is the Commander of iiV. She is an Israeli-Asian Fellow who received her MBA from Tel Aviv University on a full scholarship from the Parasol Foundation.
For more information, contact:
Merrill Weber
Phone .: (312) 340-0895
Phone .: +972- (0) 58-406-2386
Email: [email protected]
VOTIS SOURCE Subdermal Image Technologies, Ltd.
Related Links
https://www.votis.net